Bild Studie POInT

New Research Findings, Diabetes, IDF,

New Milestone Towards Personalized Prevention of Type 1 Diabetes

First results of the Primary Oral Insulin Trial (POInT) mark an important step towards the prevention of type 1 diabetes, pointing future efforts to personalized strategies. The group led by researchers from Helmholtz Munich and the Technical…

HMGU_Icon_Computat_Health

Featured Publication, Computational Health, Health AI,

TITAN: A Multimodal AI Model for Digital Pathology Slides

Scientists at Helmholtz Munich, together with Harvard Medical School and international collaborators, have developed TITAN, an artificial intelligence (AI) model capable of analyzing and describing digital pathology slides. By combining information…

NMR spectroscopy techniques

Events, Molecular Targets and Therapeutics, STB,

Biomolecular Breathing and the 4D View of Life: Insights from the BNMRZ Symposium

How do biomolecules breathe? This question guided the recent international symposium “Ultra-Highfield NMR and 4D Structural Biology – From Mechanisms to Therapies”, hosted by the Bavarian NMR Center (BNMRZ), a joint infrastructure of Helmholtz Munich…

HMGU_Icon_Environm_Health

Featured Publication, Environmental Health, LHI,

How Lung Cells Initiate the Immune Response to Nanoparticles

When nanoparticles enter the lungs, the immune system reacts within minutes. Researchers from the Institute of Lung Health and Immunity (LHI) at Helmholtz Munich have now revealed how alveolar macrophages – immune cells located in the lung’s air sacs…

Schwangere Frau mit Ultraschallbildern

New Research Findings, Diabetes, IDF,

Maternal Type 1 Diabetes May Protect Children Through Epigenetic Changes

Children with a family history of type 1 diabetes (T1D) have an increased risk of developing the disease. However, children born to mothers with T1D are less likely to develop the disease than those whose fathers or siblings have T1D. A new study…

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, MCD,

Triggering Cell Death in Metastatic Melanoma and Lung Adenocarcinoma May Pave the Way for New Cancer Treatments

Two new studies published in Nature show that metastatic melanoma and lung adenocarcinoma rely on the protein ferroptosis suppressor protein 1 (FSP1) for survival – identifying a metabolic dependency that may inform the development of new cancer…